Mairs & Power released their second-quarter 2025 investor letter, detailing a 2.66% return for the Balanced Fund. Despite underperforming benchmark indexes and peers, the fund bounced back from a challenging start to the year, rising 25% by the end of the quarter. Check out the top five holdings for insights into their best picks.

In the investor letter, Mairs & Power Balanced Fund highlighted Bio-Techne Corporation (NASDAQ: TECH), a company with a market capitalization of $8.239 billion that develops, manufactures, and sells life science reagents. Despite recent challenges, the fund has added to its Bio-Techne holdings, recognizing the company’s potential in the biopharmaceutical industry.

Bio-Techne Corporation (NASDAQ: TECH) saw 37 hedge fund portfolios holding its stock at the end of the second quarter, up from 34 in the previous quarter. In the fiscal fourth quarter of 2025, Bio-Techne generated $317 million in revenues, showing growth on an organic and reported basis. While Bio-Techne shows promise as an investment, certain AI stocks may offer greater upside potential with less downside risk.

Read more at Yahoo Finance: BioTechne (TECH) Fell Over the Industry’s Uncertain Funding Environment